CSL stock AGM on October 27, 2026 ahead of the Xetra open
Published on 10/26/2026 at 07:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnnual meeting on the agenda
- Shareholders are scheduled to attend CSL's annual general meeting on October 27, 2026.
- CSL researches, develops, manufactures, markets and distributes biopharmaceutical products and vaccines.
- CSL stock trades pre-market at EUR 121.34 at 7:34 a.m. CET at Lang & Schwarz on October 26, 2026.
CSL Limited's 2026 annual general meeting is scheduled for October 27, 2026, according to the company's investor-relations page. CSL stock trades pre-market at EUR 121.34 at 7:34 a.m. CET at Lang & Schwarz on October 26, 2026.
Annual meeting details
The meeting is set to take place at Sofitel Melbourne on Collins in Melbourne, Australia, with shareholders also able to participate online. The company lists the meeting date as Tuesday, October 27, 2026, in Australian Eastern Daylight Time. The agenda therefore includes an event specific to CSL within the next trading days. The company's investor-relations page provides the meeting information.
Pre-market trading
The bid is EUR 121.04 and the ask is EUR 121.64 at Lang & Schwarz. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of CSL stock.
Business and market focus
CSL researches, develops, manufactures, markets and distributes biopharmaceutical products and vaccines in international markets, according to a company overview published by Simply Wall St. Its operations include plasma-derived therapies, vaccines and other biopharmaceutical products. Market context: Market report S&P/ASX 200.
